AAA

Affinity Asset Advisors Portfolio holdings

AUM $676M
This Quarter Return
+0.92%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$640M
AUM Growth
+$640M
Cap. Flow
+$2.06M
Cap. Flow %
0.32%
Top 10 Hldgs %
47.48%
Holding
103
New
14
Increased
22
Reduced
20
Closed
16

Top Buys

1
APGE icon
Apogee Therapeutics
APGE
$12.1M
2
MRUS icon
Merus
MRUS
$9.57M
3
ARVN icon
Arvinas
ARVN
$7.76M
4
SYRE icon
Spyre Therapeutics
SYRE
$7.59M
5
PRQR icon
ProQR Therapeutics
PRQR
$7.49M

Top Sells

1
KURA icon
Kura Oncology
KURA
$13.4M
2
ATXS icon
Astria Therapeutics
ATXS
$7.98M
3
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
$7.86M
4
VRDN icon
Viridian Therapeutics
VRDN
$7M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
$5.4M

Sector Composition

1 Healthcare 90.96%
2 Financials 0.56%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMRN icon
76
BioMarin Pharmaceuticals
BMRN
$11.3B
– –
-15,000
Closed -$1.05M
GALT icon
77
Galectin Therapeutics
GALT
$288M
– –
0
– –
GNLX icon
78
Genelux
GNLX
$125M
– –
-100,000
Closed -$237K
IBRX icon
79
ImmunityBio
IBRX
$2.24B
– –
0
– –
IMTX icon
80
Immatics
IMTX
$662M
– –
-250,000
Closed -$2.85M
KURA icon
81
Kura Oncology
KURA
$732M
– –
-687,785
Closed -$13.4M
MESO
82
Mesoblast
MESO
$1.65B
– –
0
– –
NMRA icon
83
Neumora Therapeutics
NMRA
$283M
– –
0
– –
NVAX icon
84
Novavax
NVAX
$1.2B
– –
0
– –
PBYI icon
85
Puma Biotechnology
PBYI
$258M
– –
-250,000
Closed -$638K
PMN icon
86
ProMIS Neurosciences
PMN
$23.7M
– –
-30,643
Closed -$38.3K
ROIV icon
87
Roivant Sciences
ROIV
$8.6B
– –
-201,587
Closed -$2.33M
SAVA icon
88
Cassava Sciences
SAVA
$107M
– –
0
– –
SMMT icon
89
Summit Therapeutics
SMMT
$17.5B
– –
0
– –
SPRY icon
90
ARS Pharmaceuticals
SPRY
$1.08B
– –
0
– –
SWTX
91
DELISTED
SpringWorks Therapeutics
SWTX
– –
-147,500
Closed -$4.73M
TERN icon
92
Terns Pharmaceuticals
TERN
$651M
– –
-600,000
Closed -$5M
VSTM icon
93
Verastem
VSTM
$585M
– –
-400,000
Closed -$1.2M
VYGR icon
94
Voyager Therapeutics
VYGR
$204M
– –
-51,727
Closed -$303K
XBI icon
95
SPDR S&P Biotech ETF
XBI
$5.29B
– –
0
– –
KYTX icon
96
Kyverna Therapeutics
KYTX
$161M
– –
-119,900
Closed -$586K
MTVA
97
MetaVia Inc. Common Stock
MTVA
$16.2M
– –
-89,222
Closed -$283K
ONC
98
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
– –
-35,000
Closed -$7.86M
WHWK
99
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
– –
-47,019
Closed -$96.9K
1 2 3
4